Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Faster, slicker, customisable & ad free!Spring offer! Get NewsNow Essentials at just £2.99 a month (40% OFF!). Go ad free today!Spring offer! Upgrade now at £2.99/m (40% OFF!)

Home
Hot Topics
US
Politics
World
Sports
Business
Crypto
Entertainment
Lifestyle
Tech
Science

Novartis
Pharmaceuticals
Sanofi
Novo Nordisk
Pfizer
AstraZeneca
GSK
Johnson & Johnson
AbbVie
Topics

Advertisement

Novartis

Share

Top Latest Popular

Curium knocks out Novartis cancer drug patents in generics fight Bloomberg Law 5d

Bloomberg Law 5d

ASCO: Novartis To Face Challengers In Growing Radiopharmaceutical Space Scrip Pharma Intelligence 19:35 Thu, 11 Jun

Scrip Pharma Intelligence 19:35 Thu, 11 Jun

Stat Plus: Novartis doubles down on molecular glue strategy STAT 15:13 Thu, 11 Jun

STAT 15:13 Thu, 11 Jun

Positive Del-brax biomarker data offers early support for Novartis’s Avidity bet Scrip Pharma Intelligence 14:19 Thu, 11 Jun

Scrip Pharma Intelligence 14:19 Thu, 11 Jun

Advertisement

Novartis $12bn bet on Avidity well placed after mid-stage FSHD win Clinical Trials Arena 16:21 Thu, 11 Jun

Clinical Trials Arena 16:21 Thu, 11 Jun

Novartis' Rhapsido meets primary goal in Phase III skin disorder study Zacks 7d

Zacks 7d

Advertisement

Advertisement

Latest

In the last hour

“Voice for Her Power” Unites Sectors to Advance Equity in Breast Cancer Care Bangkok Post 03:56

Yesterday

Genentech, Novartis Accused of Drug Kickback Schemes in Lawsuit Bloomberg Law 15:36 Mon, 22 Jun

BioArctic and Lilly sign $30m collaboration combining BrainTransporter with Lilly neurodegeneration asset Manufacturing Chemist 10:25 Mon, 22 Jun

Friday

ASCO26: RLTs bring the buzz, but commercial and tolerability qualms remain Pharmaceutical Technology 09:56 Fri, 19 Jun

Thursday

Patent Claims On Novartis Unit Drug Invalid, Del. Judge Says Law360 20:28 Thu, 18 Jun

Curium Knocks Out Novartis Cancer Drug Patents in Generics Fight Bloomberg Law 01:39 Thu, 18 Jun

In the last month

Novartis' Rhapsido Meets Primary Goal in Phase III Skin Disorder Study Zacks 16:38 Mon, 15 Jun

Novartis brings in its advanced-prostrate-cancer drug to India The Hindu Business Line 11:33 Mon, 15 Jun

Novartis India launches Pluvicto for prostate cancer treatment The Economic Times 10:49 Mon, 15 Jun

Novartis' Rhapsido Shows Promise In Chronic Inducible Urticaria RTT News 13:31 Fri, 12 Jun

Advertisement

Advertisement

Advertisement

About our Novartis news

Latest news for Novartis, a global healthcare company based in Switzerland specialising in pharmaceuticals, including updates on company and product news.

News Now

Our Sites

News Now Nigeria

News Now România

News Now Italia

News Now Canada

News Now Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Business Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis